COVID can cause a long-lasting breakdown of immune homeostasis, where elevated IL-7 and IL-15 keep T cells activated for months after the acute infection.
In some people this dysregulated state becomes persistent - and may directly contribute to long COVID🧵
This is an important shift in understanding. It’s not just that T cells stay activated - the key question is why.
The new study shows that the drivers are homeostatic cytokines that normally help rebuild the T-cell pool after infection.
The problem is that COVID causes a major loss of T cells (lymphopenia).
The body responds by ramping up IL-7 and IL-15 to help replenish them.
But these cytokines become so abundant that T cells remain on standby for months - even long after the virus has cleared from the airways.
This leads to a prolonged increase in CD25 and CD122 and a decrease in CD127.
In simple terms. T cells receptors get reprogrammed to stay more reactive and slower to return to their resting state!
That’s a measurable signature of chronic immune activation.
And here’s the striking part.
It’s not only SARS-CoV-2-specific T cells that stay activated.
Bystander T cells - like those targeting EBV or influenza - show the same shift!
This means the issue isn’t persistent stimulation by viral antigen alone, but a global cytokine-driven dysregulation.
This mechanism seems variant-agnostic. The disruption comes from the depth of lymphopenia and the intensity of the acute immune response.
Most people eventually normalize both T-cell numbers and receptor expression.
But the study shows that in a subset of patients, the abnormalities persist for 6–12 months.
This is not typical for other respiratory viruses.
These individuals are also more likely to have ongoing symptoms.
Even 12 months later, they show higher CD25 on SARS-CoV-2-specific CD8 T cells
a hint that two processes may coexist
persistent viral antigens
long-term dysregulation of IL-7/IL-15 signaling.
Together, these factors create a state of low-grade chronic activation, T-cell fatigue, and impaired immune balance.
Mechanistically, this links acute COVID - immune instability - long COVID.
Why does this matter?
Because it finally identifies measurable biological mechanisms we can track - and potentially target
IL-15 signaling
dysregulated IL-7Rα
sustained CD25/CD122 elevation
delayed reconstitution of the T-cell pool!
And it also explains why vaccination doesn’t reproduce this effect.
After an mRNA booster, receptor changes fade within 30 days and only affect antigen-specific cells - not the entire T-cell population!
So, it’s an infection that can disrupt the fundamental regulatory system of T cells for months!
And this failure to return to immune equilibrium is one of the strongest mechanistic explanations for long COVID.
IL-7/IL-15 dysregulation is a central node that determines whether the immune system truly recovers or slips into chronic dysfunction.
This study is the one of first to map that mechanism in full.
Ceglarek et al., 2025. Dysregulation of homeostatic cytokine receptors drives prolonged T cell activation following acute SARS-CoV-2 infection in humans. Nature Communications. nature.com/articles/s4146…
Knowing that the T-cell regulatory system is disrupted is crucial because it determines how fast immunity recovers, how we respond to new infections, how much inflammation we generate, and whether T cells stay functional or burn out.
Key reasons this mechanism is important
Persistent antigen
If the immune system cannot switch off properly, even small amounts of residual viral protein can keep it activated.
This pattern repeatedly shows up in long COVID cohorts.
Chronic activation/exhaustion
T cells that stay on for months begin to lose range and efficiency.
Their repertoire narrows and their responses weaken - a milder version of patterns seen in chronic viral infections.
Increased susceptibility and autoimmune risk
A dysregulated T-cell environment can mean greater vulnerability to other infections, paradoxical hyper-reactivity, chronic low-grade inflammation, and a higher likelihood of autoimmune complications.
All of these are observed in subsets of long COVID patients.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
A new review breaks down what SARS-CoV-2 ORF/accessory proteins actually do - from interferon suppression to mitochondrial disruption. Here are the key points, followed by how some of these mechanisms compare to those used by HIV🧵
A new review makes something very clear.
SARS-CoV-2 doesn’t rely only on spike. It uses a broad arsenal of accessory proteins (APs) that shape
how severe the acute phase becomes,
which organs are affected,
and the biological conditions that make long-term sequelae more likely.
These proteins aren’t side notes - they’re central modules of pathogenesis.
The review goes protein by protein and shows a pattern we haven’t had clearly assembled before.
SARS-CoV-2 runs a multi-layer immune-evasion network.
Cognitive PASC (COVID brain fog with measurable cognitive decline) isn’t just another flavor of long COVID.
This new important study shows its a biologically distinct condition that carries features resembling early neurodegenerative processes - even after mild COVID🧵
Evidence of brain injury in cognitive PASC -
The cognitive PASC group shows clear signs of astroglial injury
elevated GFAP (astrocyte damage marker)
NfL not elevated, meaning no widespread axonal destruction
This suggests a chronic, low-grade neuroinflammatory–degenerative stress.
Structural changes in the cerebral cortex -
MRI reveals cortical thinning in regions essential for attention, memory and integrative processing
the cingulate cortex
the insula
the parahippocampal region
These are the same regions commonly affected in early neurodegenerative conditions.
SARS-CoV-2 causes long-lasting structural changes in the brain - even in people without symptoms.
Recovered ≠ normal. In this study, every single recovered participant still showed measurable abnormalities.
And this is 6-12 months after infection🧵
47 participants - Long COVID (19), recovered without symptoms (12), uninfected controls (16)
Multimodal 3T MRI - myelin (T1w/T2w), white matter microstructure (MD/AD/RD/FA), MR spectroscopy
Variant based on timing/location - Australia 2022–23, this was almost certainly Omicron
Headline?
Both post-COVID groups show clear structural brain differences.
Recovered often shows stronger myelin reorganization, while Long COVID shows more metabolic stress and some inflammation related diffusion patterns.
SARS-CoV-2 spike can trigger Sjögren-like damage in salivary glands - and the parallels with HIV are striking.
Salivary glands are not passive tissue. They’re immune active organs with TLR2/4, resident lymphocytes, and epithelial cells that behave like mini immune sensors🧵
A new study shows something interesting. The SARS-CoV-2 spike protein alone - without virus, without ACE2 entry - can cause significant damage to submandibular glands, closely resembling early Sjögren’s disease.
Mice injected with spike showed a sharp drop in saliva production. Histology revealed lymphocytic infiltrates around ducts and vessels - the same architecture seen in autoimmune sialadenitis.
A new 3-year scRNA-seq study shows something striking. Some people after COVID still carry an immune profile that looks like accelerated aging - low naive T cells and persistent activation of pathogenic Th17. Not a long-COVID cohort, but biologically very close🧵
The study didn’t select people with long COVID.
It followed 47 individuals after COVID-19 for 3 years - and some symptoms were reported within the cohort, allowing the authors to examine symptom-associated immune signals without defining a long-COVID subgroup.
The first major finding.
Even after 3 years, three key protective cell types remain significantly reduced
naive CD4 T cells
naive CD8 T cells
SLC4A10+ MAIT cells
This pattern is normally associated with immunosenescence.
When we look at the brain after COVID, we need to accept something that still hasn’t fully landed in public understanding - changes in cerebral perfusion aren’t limited to people with Long COVID. They show up in almost everyone.
And this new study makes that point clear🧵
What the authors demonstrate is simple but essential - the perfusion changes they found aren’t exclusive to PCC patients - they also appear in the controls, who had COVID but don’t report chronic symptoms.
So when we compare PCC patients with post-COVID controls, we’re not comparing a sick brain to a healthy one.
We’re comparing a COVID-affected brain to another COVID-affected brain.
And that fundamentally changes how we have to read the results.